Understanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's Disease

了解阿尔茨海默病中 tau 蛋白病理学与小胶质细胞介导的炎症之间的动态相互作用

基本信息

  • 批准号:
    10317631
  • 负责人:
  • 金额:
    $ 114.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract The etiology, mechanism and progression of Alzheimer’s Disease (AD), and the relationship of AD pathology to clinical manifestations, are not fully understood. Emerging studies suggest that inflammation and microglial activation is an important contributor to AD pathogenesis and progression. The association between tau and microglia is especially critical, since tau is most closely associated with AD. The conventionally accepted sequence of this interaction is that misfolded tau, which is pro-inflammatory, causes microglial activation, leading to dendritic pruning and eventually neuronal cell death. However, it is recently emerging that microglial activation can itself cause tau aggregation and subsequent propagation. Therefore the causality of these interactions is controversial, and requires much needed elucidation in humans in vivo. The goal of this proposal is to understand the interaction and causal sequencing between tau, neurodegeneration, microglia and systemic inflammation in governing the etiology and progression of human AD. This proposal involves a series of principled statistical and mathematical model-based tests that will uncover these relationships, for the first time, directly in patients. This proposal involves a new prospective longitudinal study of 100 AD spectrum patients acquiring brain MRI and PET imaging of activated microglia using a new generation TSPO ligand called DPA-713 and tau-PET imaging using a relatively novel ligand, MK6240. The same imaging protocol (MRI, DPA-713 and MK6240 PET) will be repeated at 18- and 36-month follow up time points. All subjects will have amyloid neuritic plaque density measured at baseline using florbetaben PET. Next this proposal involves developing and testing a model of microglial inflammation-tau interaction via mathematical models to determine whether regional microglia-mediated neuroinflammation measured by DPA-PET is higher in AD spectrum patients or in cognitively normal older adults; and whether regional microglial activation is predictable directly from tau and/or amyloid. Finally, this proposed research includes testing a network spread model of tau and microglia. Mounting animal data implicate a trans-neuronal transmission mechanism of tau through brain networks. Using a network diffusion model of disease spread, this proposal will further investigate the role of microglia in tau progression directly in humans. Since tau and microglia provide complementary signal about evolving pathology, this proposal will determine whether combining imaging studies that measure both biomarkers will result in a uniquely powerful and predictive test of AD progression. Given the rapidly evolving understanding of the role of microglia and systemic inflammation in dementias, the current proposal is timely, topical and necessary for advancing human dementia research. If successful, it will give the first validated spatiotemporal model of the causal interactions between pathology and neuroinflammation in AD, catalyzing future advances in prognostication and targeted anti-inflammatory therapies.
项目总结/摘要 阿尔茨海默病(AD)的病因、发病机制、进展及与病理的关系 临床表现,尚未完全了解。新的研究表明,炎症和小胶质细胞 激活是AD发病机制和进展的重要因素。tau蛋白与 小胶质细胞尤其重要,因为tau与AD最密切相关。传统上被接受的 这种相互作用的顺序是,促炎性的错误折叠的tau,引起小胶质细胞活化, 导致树突修剪并最终导致神经元细胞死亡。然而,最近出现的是, 活化本身可引起tau聚集和随后的传播。因此,这些因果关系 相互作用是有争议的,并且需要在人体内进行非常需要的阐明。这项提案的目的是 是了解tau蛋白,神经变性,小胶质细胞和 全身性炎症在人类AD的病因学和进展中的作用。该提案涉及一系列 原则性的统计和数学模型为基础的测试,将揭示这些关系,第一, 时间,直接在病人身上。该提案涉及一项新的前瞻性纵向研究, 使用新一代TSPO配体获得活化小胶质细胞的脑MRI和PET成像的患者 称为DPA-713和tau-PET成像,使用相对新颖的配体MK 6240。相同的成像协议 (MRI、DPA-713和MK 6240 PET)将在18个月和36个月随访时间点重复进行。所有受试者将 在基线时使用florbetaben PET测量淀粉样神经炎斑块密度。接下来,该提案涉及 通过数学模型开发和测试小胶质细胞炎症-tau相互作用的模型, 确定通过DPA-PET测量的局部小胶质细胞介导的神经炎症是否在AD中更高 频谱患者或认知正常的老年人;以及区域性小胶质细胞激活是否可预测 直接来自tau和/或淀粉样蛋白。最后,这项拟议的研究包括测试tau的网络传播模型 和小胶质细胞。越来越多的动物数据暗示了tau蛋白通过大脑的跨神经元传递机制 网络.使用疾病传播的网络扩散模型,该提案将进一步研究 小胶质细胞在人类的tau蛋白直接进展。由于tau蛋白和小胶质细胞提供关于 随着病理学的发展,这项建议将决定是否结合影像学研究,测量两者 生物标志物将导致AD进展的独特的强大和预测性测试。鉴于快速发展的 了解小胶质细胞和全身炎症在痴呆症中的作用,目前的建议是及时的, 这是推进人类痴呆症研究的主题和必要条件。如果成功,它将给出第一个经过验证的 AD中病理和神经炎症之间因果相互作用的时空模型,催化 未来的进展,在消炎和有针对性的抗炎治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ajay Gupta其他文献

Ajay Gupta的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ajay Gupta', 18)}}的其他基金

Development of a dry powder inhalation product against Respiratory Syncytial Virus based on an endogenous anionic pulmonary surfactant lipid
基于内源性阴离子肺表面活性剂脂质的抗呼吸道合胞病毒干粉吸入产品的开发
  • 批准号:
    10697027
  • 财政年份:
    2023
  • 资助金额:
    $ 114.16万
  • 项目类别:
Quantitative susceptibility mapping for stroke risk prediction of vulnerable carotid plaques
用于预测易损颈动脉斑块中风风险的定量敏感性图
  • 批准号:
    10446087
  • 财政年份:
    2022
  • 资助金额:
    $ 114.16万
  • 项目类别:
Quantitative Susceptibility Mapping for Stroke Risk Prediction of Vulnerable Carotid Plaques
用于预测易损颈动脉斑块中风风险的定量敏感性图
  • 批准号:
    10609912
  • 财政年份:
    2022
  • 资助金额:
    $ 114.16万
  • 项目类别:
Understanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's Disease
了解阿尔茨海默病中 tau 蛋白病理学与小胶质细胞介导的炎症之间的动态相互作用
  • 批准号:
    10622513
  • 财政年份:
    2021
  • 资助金额:
    $ 114.16万
  • 项目类别:
Understanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's Disease
了解阿尔茨海默病中 tau 蛋白病理学与小胶质细胞介导的炎症之间的动态相互作用
  • 批准号:
    10471976
  • 财政年份:
    2021
  • 资助金额:
    $ 114.16万
  • 项目类别:
MRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of undeteRmined source (MRI DECIPHER)
颈动脉斑块的 MRI 检测作为不明原因栓塞性中风的机制(MRI DECIPHER)
  • 批准号:
    10204095
  • 财政年份:
    2019
  • 资助金额:
    $ 114.16万
  • 项目类别:
A Machine Learning Approach For CTA-based Plaque Characterization and Stroke Risk Prediction in Carotid Artery Atherosclerosis
基于 CTA 的颈动脉粥样硬化斑块表征和中风风险预测的机器学习方法
  • 批准号:
    9904175
  • 财政年份:
    2019
  • 资助金额:
    $ 114.16万
  • 项目类别:
MRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of undeteRmined source (MRI DECIPHER)
颈动脉斑块的 MRI 检测作为不明原因栓塞性中风的机制(MRI DECIPHER)
  • 批准号:
    10661676
  • 财政年份:
    2019
  • 资助金额:
    $ 114.16万
  • 项目类别:
MRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of undeteRmined source (MRI DECIPHER)
颈动脉斑块的 MRI 检测作为不明原因栓塞性中风的机制(MRI DECIPHER)
  • 批准号:
    10449116
  • 财政年份:
    2019
  • 资助金额:
    $ 114.16万
  • 项目类别:
Parallel Algorithms for Big Data from Mass Spectrometry based Proteomics
基于质谱的蛋白质组学大数据并行算法
  • 批准号:
    9301702
  • 财政年份:
    2017
  • 资助金额:
    $ 114.16万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 114.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 114.16万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 114.16万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 114.16万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 114.16万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 114.16万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 114.16万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 114.16万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 114.16万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 114.16万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了